A Generic Industry Approach To Demonstrate Efficient Purification of Potential Mutagenic Impurities in the Synthesis of Drug Substances

Determination of theoretical purge factors for the evaluation of risk of carryover of potential mutagenic impurities (MIs) into the final active pharmaceutical ingredient (API) has been discussed as a possible approach to demonstrate efficient purification of potential MIs (Substances I, II, III, and IV) in the synthesis of the vortioxetine drug substance. Theoretical purge factors for the four potential MIs were determined based on the physicochemical properties of an MI in relation to processing conditions. Compared to depletion studies of I and III, the calculated purge factors were very conservative in predicting impurities reduction. However, even a conservatively calculated purge factor correctly predicted high purging capability of the process to eliminate substance I. This novel approach could help pharmaceutical companies to focus on those impurities that are more likely to be carried over into the final API, thus obviating the use of analytical testing where not necessary.

[1]  Lutz Müller,et al.  A rationale for determining, testing, and controlling specific impurities in pharmaceuticals that possess potential for genotoxicity. , 2006, Regulatory toxicology and pharmacology : RTP.

[2]  L. Povirk,et al.  DNA damage and mutagenesis induced by nitrogen mustards. , 1994, Mutation research.

[3]  Andrew Teasdale,et al.  A Tool for the Semiquantitative Assessment of Potentially Genotoxic Impurity (PGI) Carryover into API Using Physicochemical Parameters and Process Conditions , 2010 .

[4]  E. Delaney,et al.  An impact analysis of the application of the threshold of toxicological concern concept to pharmaceuticals. , 2007, Regulatory toxicology and pharmacology : RTP.

[5]  E. Zeiger,et al.  Chromosome aberrations and sister chromatid exchanges in chinese hamster ovary cells: Evaluations of 108 chemicals , 1987, Environmental and molecular mutagenesis.

[6]  Michael A. McGuire,et al.  Assessment of Predictivity of Semiquantitative Risk Assessment Tool: Pazopanib Hydrochloride Genotoxic Impurities , 2013 .

[7]  N V V S S Raman,et al.  Strategies for the identification, control and determination of genotoxic impurities in drug substances: a pharmaceutical industry perspective. , 2011, Journal of pharmaceutical and biomedical analysis.

[8]  E. Zeiger,et al.  Salmonella mutagenicity tests: III. Results from the testing of 255 chemicals. , 1987, Environmental mutagenesis.

[9]  E. Deeks,et al.  Vortioxetine: First Global Approval , 2013, Drugs.

[10]  H. Matsushita,et al.  [Mutagenicity of aliphatic and aromatic nitro compounds. Industrial materials and related compounds]. , 1987, Sangyo igaku. Japanese journal of industrial health.

[11]  B. Ames,et al.  Detection of carcinogens as mutagens in the Salmonella/microsome test: assay of 300 chemicals. , 1975, Proceedings of the National Academy of Sciences of the United States of America.

[12]  Andrew Teasdale,et al.  Risk Assessment of Genotoxic Impurities in New Chemical Entities: Strategies To Demonstrate Control , 2013 .